- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05068882
Impact of Oral Diets on Postoperative Fluid Collection (BC1)
October 5, 2021 updated by: Stanislaw Klek, Stanley Dudrick's Memorial Hospital
Impact of Preoperative Oral Diets on Postoperative Fluid Collection After Axillary Lymphadenectomy
Patients after the surgical removal of axillary lymphnodes suffers from prolonged fluid collections.
The aim of the study is to assess the impact of oral immunonutrition and high-protein diets on the reduction of fluid collection.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Patients after the surgical removal of axillary lymphnodes suffers from prolonged fluid collections, which requires either prolonged drainage or multiple punctuations.
The aim of the study is to assess the impact of oral immunonutrition and high-protein diets on the reduction of fluid collection.
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Skawina, Poland, 32-050
- Recruiting
- Stanley Dudrick's Memorial Hospital
-
Contact:
- Stanislaw Klek, Assoc. Prof.
- Phone Number: +48604293566
- Email: klek@poczta.onet.pl
-
Principal Investigator:
- Stanislaw Klek, Assoc. Prof.
-
-
Malopolska
-
Kraków, Malopolska, Poland, 31-115
- Recruiting
- Maria Sklodowska-Curie National Cancer Institute
-
Contact:
- Narodowy I Onkologii
- Phone Number: 60293566
- Email: stanislaw.klek@onkologia.krakow.pl
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- confirmed breast cancer or melanoma
- scheduled surgery with axillary lymph nodes resection
- informed consent
- eligible for surgery
Exclusion Criteria:
- benign disease
- no consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No intervention
|
|
Experimental: Immunonutrition
Oral immunonutrition containing arginine, omega-PUFAs and antioxidants
|
Oral immunonutrition containing arginine, omega-PUFAs and antioxidants
|
Active Comparator: High-protein diet
Oral nutrition with high-protein content
|
Oral nutrition with high-protein content
|
Active Comparator: Standard nutrition
Oral nutrition with standard ingredients
|
Oral nutrition with standard ingredients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fluid collection
Time Frame: 6 months
|
The volume of fluid collection after lymph nodes resection expressed in mililiters
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Anticipated)
January 31, 2023
Study Completion (Anticipated)
March 31, 2023
Study Registration Dates
First Submitted
September 25, 2021
First Submitted That Met QC Criteria
September 25, 2021
First Posted (Actual)
October 6, 2021
Study Record Updates
Last Update Posted (Actual)
October 13, 2021
Last Update Submitted That Met QC Criteria
October 5, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BC1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Complications
-
Marmara UniversityHacettepe University; Cukurova University; Gazi University; Baskent University; Istanbul... and other collaboratorsNot yet recruitingComplications, PostoperativeTurkey
-
Syed HusainRecruitingComplications, PostoperativeUnited States
-
Vastra Gotaland RegionRecruitingSurgery | Lung Infection | Complications, PostoperativeSweden
-
University of PittsburghCompletedLiver Transplant; Complications | Perioperative/Postoperative ComplicationsUnited States
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
Wake Forest University Health SciencesTerminatedPerioperative/Postoperative ComplicationsUnited States
-
Technical University of MunichHealth Information Management, BelgiumActive, not recruitingPerioperative/Postoperative Complications
-
Atatürk Chest Diseases and Chest Surgery Training...CompletedPerioperative/Postoperative ComplicationsTurkey
-
Namigar TurgutCompletedPerioperative/Postoperative ComplicationsTurkey
-
TC Erciyes UniversityCompletedPerioperative/Postoperative ComplicationsTurkey
Clinical Trials on Immunonutrition
-
Centre Hospitalier Universitaire VaudoisHôpital Riviera-Chablais, Vaud-Valais; Insel Gruppe AG, University Hospital...RecruitingEndometriosis | Bladder Cancer | Interstitial Cystitis | Neurogenic Bladder | Bladder Disease | Painful Bladder Syndrome | Hemorrhagic CystitisSwitzerland
-
University of Rome Tor VergataCompletedGastric Cancer | Surgery | Gastric Neoplasm | Digestive Cancer | Laparoscopic
-
University of Rome Tor VergataCompleted
-
Columbia UniversityAbbott NutritionRecruitingHeart Failure | Gut Microbiome | Nutritional DeficiencyUnited States
-
St. Antonius HospitalUnknownRespiratory Insufficiency | Thoracic Aortic AneurysmNetherlands
-
Jagiellonian UniversityCompletedColon Cancer | Nutrition Aspect of CancerPoland
-
Hospital General Universitario ElcheFundación Mutua MadrileñaCompleted
-
Saglik Bilimleri UniversitesiHaydarpasa Numune Training and Research HospitalCompletedColorectal CancerTurkey
-
SHUANGZHENGJIARecruitingCervical CancersChina